Medios AG (OTCMKTS:MEDOF) Sees Large Increase in Short Interest

Medios AG (OTCMKTS:MEDOF) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totaling 2,705 shares, an increase of 215.3% from the September 30th total of 858 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ? days.

Medios Price Performance

Shares of MEDOF opened at C$13.64 on Friday. The company has a 50 day moving average price of C$13.64 and a 200-day moving average price of C$13.64. Medios has a fifty-two week low of C$13.64 and a fifty-two week high of C$13.64.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Medios in a report on Thursday, August 13th. One research analyst has rated the stock with a Buy rating. According to MarketBeat.com, the stock presently has a consensus rating of “Buy”.

About Medios

Medios AG is a Germany-based specialty pharmaceutical company headquartered in Berlin. The company focuses on supplying medicines and services for complex, often chronic or rare diseases, supporting healthcare providers and pharmacies involved in specialized patient care.

Its activities include the procurement, distribution and supply of specialty pharmaceuticals, as well as the preparation of patient-specific medications. Medios also provides pharmaceutical compounding services, producing individualized therapies in accordance with medical prescriptions and applicable quality standards.

Medios serves customers primarily in Germany through relationships with pharmacies, hospitals, medical practices and other healthcare partners.